Accel eyes stake in India’s Truemeds at $330 million valuation

According to half a dozen sources, Accel, the global venture firm, is in advanced discussions to lead a funding round of $30 million to $40 million in Truemeds, an Indian online pharmacy that’s focused on providing customers with more affordable generic alternatives to costly branded medications. The talks are currently centered on a proposed valuation […]

© 2024 TechCrunch. All rights reserved. For personal use only.